PharmaLex seals merger with UK’s NeoHealthHub
Agreement will be key to building a pan-European market access practice
Read Moreby John Pinching | Oct 13, 2022 | News | 0
Agreement will be key to building a pan-European market access practice
Read Moreby Selina McKee | Apr 23, 2020 | News | 0
The decision ensures that the merger between Mylan and Upjohn does not harm competition
Read Moreby Anna Smith | Jun 26, 2019 | News | 0
The deal is the second huge merger this year, after January’s Bristol-Myers Squibb & Celgene deal.
Read Moreby Anna Smith | Apr 16, 2019 | News | 0
The decision was won by a majority of more than 75%.
Read Moreby Selina McKee | Apr 25, 2018 | News | 0
Shire’s Board has notified Takeda that it would be “willing to recommend” the latter’s latest merger proposal to shareholders, which is now valued at £46 billion pounds.
Read Moreby Selina McKee | Apr 23, 2018 | News | 0
German healthcare firm Fresenius Kabi is walking away from a $4.3-billion merger with US generics group Akorn, claiming that the latter has failed to fulfill several closing conditions.
Read Moreby Selina McKee | Mar 29, 2018 | News | 0
Takeda has revealed that it is considering making a move on Shire to add ballast to its core therapeutic areas.
Read Moreby Selina McKee | Aug 31, 2017 | News | 0
The Competition and Markets Authority has cleared a merger between Heart of England NHS Foundation Trust (HEFT) and University Hospitals Birmingham NHS Foundation Trust (UHB).
Read Moreby Selina McKee | Jun 12, 2017 | News | 0
The European Commission has issued a conditional green light for Johnson & Johnson’s planned $30 billion purchase of Actelion, laying out the commitments it feels are necessary to ensure that clinical development of the firms’ innovative insomnia drugs will not be adversely affected by the merger.
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479